MASI DINA (Chief Financial Officer) received a stock award from INTEGRATED BIOPHARMA INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/22/2025ACC: 0001345281-25-000002
Officer· Chief Financial Officer
Since May 2019
0.00
Net shares
Net seller
$12.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
135K acquired · 135K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+135K
Price / share
$0.09
Trade value
$12.15K
% of position
63.6%
5/21/2025
212.20K→347.20K
Total
Net shares
+135K
Net value
$12.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2025 | A · Award | +135K | $0.09 | $12.15K | 63.6% | 212.20K | 347.20K |
| Total | +135K | $12.15K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
135K shares
Shares
−135K
Strike price
0.09
Held after
0.00
Exercisable
—
5/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock135K shares | 5/21/2025 | D · Disposition | −135K | 0.09 | — | 0.00 |